Vincerx Pharma Inc. (VINC)
Market Closed
11 Aug, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 01
0
0%
$
66.47K Market Cap
- P/E Ratio
- Div Yield
1,400 Volume
-1.02 Eps
$ 0.01
Previous Close Want to track VINC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
What Makes Vincerx Pharma (VINC) a New Buy Stock
Vincerx Pharma (VINC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks | 1 year ago
Penny Stock Cancer-Focused Vincerx Pharma Seeks Development Partner For 2 Early-Stage Blood Cancer Candidates
On Monday, Vincerx Pharma VINC shared updates on its ongoing Phase 1 studies of VIP943, VIP236, and enitociclib, which aim to address various blood cancers.
Benzinga | 1 year ago
Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade
Vincerx Pharma (VINC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks | 2 years ago
